![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » StimGuard Approved for Sacral Nerve Stimulator
StimGuard Approved for Sacral Nerve Stimulator
![Purple_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Purple_Approved_Stamp.gif?t=1576639773&width=430)
StimGuard’s wireless neuromodulation device received a CE Mark for treating chronic, persistent symptoms of overactive bladder.
The device injects a therapy using a needle and can be configured using an Apple iPad for advanced programming. It eliminates the need for implantation of a battery source in the patient, which requires surgery.
The nerve stimulator places a small device equipped with electrode contacts and an embedded chip in the patient’s body through a needle paired with a wire receiver.
Upcoming Events
-
21Oct